IRIS
MARTINI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.423
NA - Nord America 1.825
AS - Asia 1.319
SA - Sud America 246
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 35
OC - Oceania 5
Totale 6.930
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.765
US - Stati Uniti d'America 1.691
RU - Federazione Russa 978
CN - Cina 371
SG - Singapore 362
BR - Brasile 195
SE - Svezia 148
HK - Hong Kong 144
NL - Olanda 137
JP - Giappone 112
VN - Vietnam 108
DE - Germania 86
CA - Canada 72
FR - Francia 70
BD - Bangladesh 60
IN - India 57
GB - Regno Unito 51
FI - Finlandia 39
TR - Turchia 35
ES - Italia 24
MX - Messico 24
PL - Polonia 22
AR - Argentina 17
AT - Austria 17
IQ - Iraq 12
LT - Lituania 11
ZA - Sudafrica 11
CO - Colombia 10
UA - Ucraina 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
ID - Indonesia 9
CR - Costa Rica 7
IE - Irlanda 7
DK - Danimarca 6
EC - Ecuador 6
GT - Guatemala 6
NO - Norvegia 6
PT - Portogallo 6
CL - Cile 5
MA - Marocco 5
NG - Nigeria 5
NI - Nicaragua 5
PE - Perù 5
PH - Filippine 5
PK - Pakistan 5
SV - El Salvador 5
AU - Australia 4
BG - Bulgaria 4
DZ - Algeria 4
GR - Grecia 4
IL - Israele 4
UZ - Uzbekistan 4
VE - Venezuela 4
BE - Belgio 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
IR - Iran 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
MY - Malesia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
CY - Cipro 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.855
Salva come PNG Salva come JPEG
Città #
Ashburn 336
Milan 296
Singapore 200
Moscow 173
San Jose 165
Dallas 157
Rome 148
Hong Kong 139
New York 96
Shanghai 73
Beijing 65
Council Bluffs 62
Los Angeles 54
Turin 47
Hefei 42
Bologna 41
Verona 38
Boardman 36
Munich 35
Florence 34
Lauterbourg 34
Phoenix 34
Ho Chi Minh City 33
Santa Clara 32
Tokyo 32
Lawrence 28
Princeton 28
Genoa 25
Hanoi 24
Orem 23
São Paulo 23
Bari 22
Brooklyn 22
Montreal 22
Palermo 22
Pune 21
Helsinki 20
Catania 17
Frankfurt am Main 17
Naples 16
North Bergen 16
Denver 15
Toronto 15
Warsaw 15
Amsterdam 13
Atlanta 13
Chennai 13
Chicago 13
Miano 13
Turku 12
Azzano San Paolo 11
Bolzano 11
Da Nang 11
Trieste 11
Mexico City 10
Modena 10
Paris 10
The Dalles 10
Brescia 9
Manchester 9
Vienna 9
Columbus 8
Houston 8
Ankara 7
Bergamo 7
Bursa 7
Cascina 7
Dublin 7
Guangzhou 7
Johannesburg 7
Lamezia Terme 7
London 7
Mumbai 7
Nuremberg 7
Padova 7
Perugia 7
Porto Alegre 7
Prato 7
Venice 7
Washington 7
Brasília 6
Haiphong 6
Hayamiya 6
Istanbul 6
Miami 6
Montepulciano 6
Parma 6
Pesaro 6
Poplar 6
Reggio Emilia 6
Rio de Janeiro 6
San José 6
Seattle 6
Stockholm 6
Treviso 6
Andria 5
Calgary 5
Erbil 5
Falconara Marittima 5
Guayaquil 5
Totale 3.231
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 2.147
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 187
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 177
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 158
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 150
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 149
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 145
How to Select the Optimal Candidates for Renal Mass Biopsy 144
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 143
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 138
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 138
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 130
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 130
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 128
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 125
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 122
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 122
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 117
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 115
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 111
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 110
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 106
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 106
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 106
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 105
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 105
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 103
The obesity paradox in metastatic castration-resistant prostate cancer 103
Citrullination licenses calpain to decondense nuclei in neutrophil extracellular trap formation 101
A Plea for Economically Sustainable Evidence-based Guidelines 97
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 96
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 96
Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impact of Age at the Time of Surgery 94
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 92
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 86
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 79
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 76
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 72
UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment of Penile Cancer 70
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 65
RE: Validating the Martini Staging System for Rectourethral Fistula: A Meta-analysis of Postoperative Outcomes 64
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients 58
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 58
Adjuvant pembrolizumab plus belzutifan versus placebo in clear cell renal cell carcinoma: a reconstructed survival data analysis of the KEYNOTE-564 and the LITESPARK-022 trials 15
Surgical repair of post-cesarean vesicouterine fistula: A systematic review and a plea for prevention 15
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials 11
Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinoma 10
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration 10
HER2 and urothelial carcinoma: current understanding and future directions 10
Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer 8
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma 6
Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring 6
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy 5
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival 5
The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy 4
null 1
Totale 6.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.177
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202299 0 0 0 18 7 6 14 11 5 9 17 12
2022/2023385 74 60 28 21 21 58 27 41 20 5 18 12
2023/2024751 18 21 31 50 53 133 41 156 12 60 71 105
2024/20251.478 163 64 128 75 87 124 202 164 189 97 74 111
2025/20263.347 243 198 192 422 305 119 270 277 836 193 101 191
2026/2027848 235 148 139 326 0 0 0 0 0 0 0 0
Totale 6.930